Video

Overcoming Immunogenicity and Manufacturing Challenges in Adenoviral Gene Therapy

Source: Cell & Gene

In this segment of Cell & Gene Live, Advancing Gene Delivery: LNPs, Adenovirus, Lentivirus, And More, Francesca Barone, M.D., Ph.D., CSO at Candel Therapeutics and Karen Kozarsky, Ph.D., President of Vector BioPartners explore strategies to overcome immunogenicity and toxicity in adenoviral vectors, discussing the benefits of intratumoral delivery, serotype switching, and viral gene deletions.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)